GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
They are free from any artificial flavors and have a shelf life of 18 months
The key is monitoring body composition with DEXA scanning so you know what you're actually losing
Some individuals cannot tolerate the nausea, vomiting, and digestive disruption that GLP-1 medications cause
Improve immune function
Available on NHS prescription and over the counter at lower doses